MX2016006125A - Procedimiento, matriz y uso de los mismos. - Google Patents
Procedimiento, matriz y uso de los mismos.Info
- Publication number
- MX2016006125A MX2016006125A MX2016006125A MX2016006125A MX2016006125A MX 2016006125 A MX2016006125 A MX 2016006125A MX 2016006125 A MX2016006125 A MX 2016006125A MX 2016006125 A MX2016006125 A MX 2016006125A MX 2016006125 A MX2016006125 A MX 2016006125A
- Authority
- MX
- Mexico
- Prior art keywords
- pancreatic cancer
- array
- determining
- individual
- test sample
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
-
- G01N33/57525—
-
- G01N33/5758—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1319878.3A GB201319878D0 (en) | 2013-11-11 | 2013-11-11 | Method, Array and use thereof |
| PCT/GB2014/053340 WO2015067969A2 (en) | 2013-11-11 | 2014-11-11 | Method, array and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016006125A true MX2016006125A (es) | 2016-08-12 |
Family
ID=49818441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016006125A MX2016006125A (es) | 2013-11-11 | 2014-11-11 | Procedimiento, matriz y uso de los mismos. |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20160252513A1 (enExample) |
| EP (1) | EP3069143B1 (enExample) |
| JP (1) | JP6600637B2 (enExample) |
| KR (1) | KR102240473B1 (enExample) |
| CN (1) | CN105917230B (enExample) |
| AU (1) | AU2014345484B2 (enExample) |
| BR (1) | BR112016010510A2 (enExample) |
| CA (1) | CA2930211A1 (enExample) |
| ES (1) | ES2704888T3 (enExample) |
| GB (1) | GB201319878D0 (enExample) |
| MX (1) | MX2016006125A (enExample) |
| WO (1) | WO2015067969A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3851856A3 (en) | 2007-03-27 | 2021-11-03 | Immunovia AB | Method, array and use thereof |
| GB201014837D0 (en) | 2010-09-07 | 2010-10-20 | Immunovia Ab | Biomarker signatures and uses thereof |
| GB201103726D0 (en) | 2011-03-04 | 2011-04-20 | Immunovia Ab | Method, array and use thereof |
| CN105021825B (zh) * | 2015-07-09 | 2016-08-17 | 陈勇 | 一种检测胰腺癌相关多肽dap44的elisa试剂盒 |
| GB201516801D0 (en) | 2015-09-22 | 2015-11-04 | Immunovia Ab | Method, array and use thereof |
| GB201608192D0 (en) * | 2016-05-10 | 2016-06-22 | Immunovia Ab | Method, array and use thereof |
| GB201609950D0 (en) * | 2016-06-07 | 2016-07-20 | Immunovia Ab | Biomarkers signatures and uses thereof |
| GB201609951D0 (en) * | 2016-06-07 | 2016-07-20 | Immunovia Ab | Biomarkers signatures and uses thereof |
| EP4053557A1 (en) * | 2016-11-24 | 2022-09-07 | Huvet Bio, Inc. | Il-29 as a marker for a pancreatic disease |
| GB201701572D0 (en) * | 2017-01-31 | 2017-03-15 | Immunovia Ab | Methods, arrays and uses thereof |
| KR102536314B1 (ko) * | 2018-05-23 | 2023-05-25 | 주식회사 휴벳바이오 | 질환의 진단용 조성물 |
| US11487739B2 (en) | 2019-02-19 | 2022-11-01 | Nasdaq, Inc. | System and methods for data model detection and surveillance |
| CA3138991A1 (en) * | 2019-05-02 | 2020-11-05 | Ligandal, Inc. | Methods and compositions for diagnostically-responsive ligand-targeted delivery of therapeutic agents |
| US20220326243A1 (en) * | 2019-05-21 | 2022-10-13 | Acurasysbio Co., Ltd. | Composition for cancer diagnosis |
| GB202010970D0 (en) | 2020-07-16 | 2020-09-02 | Immunovia Ab | Methods, arrays and uses thereof |
| KR102226826B1 (ko) * | 2020-08-06 | 2021-03-11 | 주식회사 휴벳바이오 | 버피 코트 시료에 사용하기 위한 췌장암 진단용 조성물 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0039578B1 (en) | 1980-05-02 | 1985-04-10 | Edward P. Davis | Leg aid device |
| US4486530A (en) | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US5856090A (en) | 1994-09-09 | 1999-01-05 | The Scripps Research Institute | DNA-methylase linking reaction |
| GB9703369D0 (en) | 1997-02-18 | 1997-04-09 | Lindqvist Bjorn H | Process |
| US6727066B2 (en) * | 2000-07-28 | 2004-04-27 | Incyte Corporation | Genes expressed in treated human C3A liver cell cultures |
| AU2003230838A1 (en) * | 2002-04-05 | 2003-10-27 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of | Methods of diagnosing potential for metastasis or developing hepatocellular carcinoma and of identifying therapeutic targets |
| CN1703524B (zh) * | 2002-09-30 | 2010-04-07 | 肿瘤疗法科学股份有限公司 | 与人胰腺癌相关的基因和多肽 |
| US7250496B2 (en) * | 2002-11-14 | 2007-07-31 | Rosetta Genomics Ltd. | Bioinformatically detectable group of novel regulatory genes and uses thereof |
| US7217807B2 (en) * | 2002-11-26 | 2007-05-15 | Rosetta Genomics Ltd | Bioinformatically detectable group of novel HIV regulatory genes and uses thereof |
| AU2004255216B2 (en) * | 2003-07-01 | 2010-08-19 | Immunomedics, Inc. | Multivalent carriers of bi-specific antibodies |
| CN102344493B (zh) * | 2004-05-28 | 2014-09-03 | 艾更斯司股份有限公司 | 结合于psca蛋白的用于癌症诊断的抗体 |
| US8383357B2 (en) * | 2005-03-16 | 2013-02-26 | OSI Pharmaceuticals, LLC | Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors |
| EP1871911A2 (en) * | 2005-04-07 | 2008-01-02 | Chiron Corporation | Cancer-related genes (prlr) |
| JP2007051880A (ja) * | 2005-08-15 | 2007-03-01 | Tokyo Univ Of Science | 膵臓癌の検出方法、膵臓癌の診断キット |
| DK1974058T3 (da) * | 2006-01-11 | 2014-09-01 | Genomic Health Inc | Genekspressionsmarkører til prognosticering af kolorektal cancer |
| EP3851856A3 (en) * | 2007-03-27 | 2021-11-03 | Immunovia AB | Method, array and use thereof |
| SG182976A1 (en) * | 2007-06-29 | 2012-08-30 | Ahngook Pharmaceutical Co Ltd | Predictive markers for ovarian cancer |
| WO2009111067A2 (en) * | 2008-03-07 | 2009-09-11 | Osi Pharmaceuticals, Inc. | Methods for the identification of agents that inhibit mesenchymal -like tumor cells or their formation |
| GB0815846D0 (en) * | 2008-09-01 | 2008-10-08 | Immunovia Ab | diagnosis, prognosis and imaging of disease |
| CN113189342B (zh) * | 2009-03-12 | 2024-12-03 | 癌症预防和治疗有限公司 | 鉴定、评估、预防以及治疗肺疾病的方法及试剂盒 |
| WO2011039289A1 (de) * | 2009-09-29 | 2011-04-07 | Protagen Ag | Markersequenzen für pankreaskrebserkrankungen, pankreaskarzinom und deren verwendung |
| MY185582A (en) * | 2010-01-07 | 2021-05-24 | Malaysian Palm Oil Board | Anti-obesity and anti-dyslipidemic effects of oil palm phenolics in preventing atheroslerosis and cardiovascular disease |
| CN102279264A (zh) * | 2010-06-09 | 2011-12-14 | 李彬 | 48种恶性肿瘤标志物抗体芯片的制备方法 |
| US20120040858A1 (en) * | 2010-08-13 | 2012-02-16 | Morehouse School Of Medicine | Biomarkers for stroke |
| GB201103726D0 (en) * | 2011-03-04 | 2011-04-20 | Immunovia Ab | Method, array and use thereof |
| WO2012139628A1 (en) * | 2011-04-11 | 2012-10-18 | Lykera Biomed Sa | Coding polypurine hairpins for the treatment of cancer |
-
2013
- 2013-11-11 GB GBGB1319878.3A patent/GB201319878D0/en not_active Ceased
-
2014
- 2014-11-11 MX MX2016006125A patent/MX2016006125A/es unknown
- 2014-11-11 BR BR112016010510A patent/BR112016010510A2/pt not_active IP Right Cessation
- 2014-11-11 AU AU2014345484A patent/AU2014345484B2/en not_active Ceased
- 2014-11-11 US US15/035,953 patent/US20160252513A1/en not_active Abandoned
- 2014-11-11 CA CA2930211A patent/CA2930211A1/en not_active Abandoned
- 2014-11-11 CN CN201480071589.2A patent/CN105917230B/zh not_active Expired - Fee Related
- 2014-11-11 KR KR1020167015574A patent/KR102240473B1/ko not_active Expired - Fee Related
- 2014-11-11 EP EP14815406.5A patent/EP3069143B1/en not_active Not-in-force
- 2014-11-11 WO PCT/GB2014/053340 patent/WO2015067969A2/en not_active Ceased
- 2014-11-11 JP JP2016552704A patent/JP6600637B2/ja not_active Expired - Fee Related
- 2014-11-11 ES ES14815406T patent/ES2704888T3/es active Active
-
2018
- 2018-10-16 US US16/161,741 patent/US20190128891A1/en not_active Abandoned
-
2022
- 2022-03-25 US US17/704,057 patent/US20220214344A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20160085327A (ko) | 2016-07-15 |
| AU2014345484A1 (en) | 2016-06-30 |
| US20190128891A1 (en) | 2019-05-02 |
| AU2014345484B2 (en) | 2020-08-27 |
| EP3069143B1 (en) | 2018-10-10 |
| CN105917230B (zh) | 2020-06-16 |
| ES2704888T3 (es) | 2019-03-20 |
| CN105917230A (zh) | 2016-08-31 |
| US20160252513A1 (en) | 2016-09-01 |
| JP2016537652A (ja) | 2016-12-01 |
| CA2930211A1 (en) | 2015-05-14 |
| GB201319878D0 (en) | 2013-12-25 |
| JP6600637B2 (ja) | 2019-10-30 |
| US20220214344A1 (en) | 2022-07-07 |
| BR112016010510A2 (pt) | 2017-12-05 |
| WO2015067969A2 (en) | 2015-05-14 |
| KR102240473B1 (ko) | 2021-04-15 |
| WO2015067969A3 (en) | 2015-08-06 |
| EP3069143A2 (en) | 2016-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2016006125A (es) | Procedimiento, matriz y uso de los mismos. | |
| MX363201B (es) | Procedimiento, matriz y uso para determinar la presencia de cancer pancreatico. | |
| MX2018013621A (es) | Metodo, matriz y uso de estos. | |
| BR112017010406A2 (pt) | processo de realização de teste de alta produtividade de cromatografia líquida de alta eficiência | |
| MX2019008911A (es) | Metodos, matrices y usos de estos. | |
| MX2017003790A (es) | Detección de secuencias diana por percepción de nanoporos de sondas sintéticas. | |
| MX2017015011A (es) | Ensayo a base de celulas para detectar homodimeros anti-cd3. | |
| WO2017050939A3 (en) | Method and array for diagnosing pancreatic cancer in an individual | |
| BR112016027475A2 (pt) | kit, dispositivo e método para a detecção de câncer pancreático | |
| BR112016019836A2 (pt) | método para analisar uma amostra de um sujeito, dispositivo de diagnóstico para utilização no diagnóstico da endometriose, kit, uso de um biomarcador, e, método para aumentar uma resposta de anticorpos em um sujeito | |
| BR112016029583A2 (pt) | ?kit ou dispositivo para a detecção de câncer esofágico e método de detecção? | |
| MX2016001719A (es) | Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular. | |
| MX383381B (es) | Métodos y composiciones para detectar proteínas mal plegadas. | |
| MX2017010836A (es) | Panel biomarcador para la deteccion de cancer. | |
| BR112016008970A2 (pt) | Método de ativação ex vivo e para avaliar ativação plasmática em um indivíduo, ensaio ex vivo para determinar atividade de calicreína plasmática em uma amostra | |
| AR089825A1 (es) | Metodo para determinar la ubicacion, tamaño y condiciones in situ en un yacimiento de hidrocarburos con ecologia, geoquimica y grupos de biomarcadores | |
| CL2017001212A1 (es) | Composiciones, dispositivos y método para pruebas de sensibilidad de síndrome del intestino irritable | |
| IL253710B (en) | Biomarkers for pancreatic cancer and kits and methods for detecting same | |
| UY36223A (es) | Dispositivos para ensayos, métodos para realizar ensayos, kits para ensayos y método para fabricar dispositivos para ensayos | |
| MX2016016742A (es) | Ceramidas y su uso en el diagnostico de enfermedad cardiovascular (ecv). | |
| BR112018015965A2 (pt) | método para determinação de helicobacter pylori | |
| MX2018005448A (es) | Metodos para la deteccion de apolipoproteinas. | |
| BR112018000452A2 (pt) | medições de função de barreira | |
| MX2017001134A (es) | Composiciones y metodos para la deteccion y analisis de tuberculosis micobacteriana. | |
| MX374601B (es) | Procedimientos y series para su uso en los mismos. |